Poland· PL-100246169

Numeta G16%E

A lösungen zur parenteralen ernährung, kombinationen product containing preparat złożony, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNumeta G16%EATCB05BA10REGISTER NO.PL-100246169PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Preparat złożony
Manufacturer
Baxter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990863396

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f75c42b1-0e6e-4630-accb-73948a774ca5
GET /v1/drugs/f75c42b1-0e6e-4630-accb-73948a774ca5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsja do infuzji",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990863396 ¦ Rp ¦ 66085\n6 worków 500 ml",
  "substance": "izoleucyna 0,86 g/500ml + Leucinum 1,29g/500ml + Lisinum monohydricum 1,42 (1,59) g/500 ml + Methioninum 0,31g/500 ml + fenyloalanina 0,54g/500ml + Treoninum 0,48g/500ml + Tryptophanum 0,26g/500ml + Valinum 0,98g/500ml + Arginina 1,08g/500ml + Histidinum 0,49g/500ml + Glicyna 0,51g/500ml + Serinum 0,51g/500ml + Alaninum 1,03g/500ml + Acidum asparaginicum 0,77g/500ml + Cysteinum 0,24g/500ml + Glutamic acid 1,29g/500ml + prolina 0,39g/500ml + Ornithini hydrochloridum 0,32 (0,41)g/500ml + Tauryna 0,08g/500ml + Tyrosine 0,10g/500ml + Sodu chlorek 0,30g/500ml + Sodu glicerynofosforan uwodniony 0,98g/500ml + Kalii acetas 1,12g/500ml + wapnia chlorek dwuwodny 0,46g/500ml + Magnesii acetas tetrahydricus 0,33g/500ml + Glucosum monohydricum 85,25 (77,50) g/500ml + Olivae oleum raffinatum 15,5g/500ml",
  "common_name": "Preparat złożony",
  "pl_product_id": "100246169",
  "pozwolenie_nr": "18172",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.